# Cyclops MedTech Pvt.

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/cyclops-medtech-pvt

- Industry: Healthcare Specialists
- Headquarters: Bangalore, India
- Website: www.cyclopsmedtech.com
- Total disclosed funding: $1M
- Latest round: Seed (Sep 19, 2018)
- Investors on record: 1

## About

Cyclops MedTech Pvt. Ltd. designs and manufactures advanced vestibular solutions aimed at diagnosing and treating dizziness and balance disorders within clinical settings.Founded in 2015, Cyclops MedTech Pvt. Ltd. is based in Bangalore, India, and specializes in vestibular diagnostics and treatment. The company has raised USD 1.00 mn in Seed funding led by Capria Ventures on September 19, 2018. The founder, Niranjan Subbarao, has a background in developing medical technologies and serves as the CEO.Cyclops MedTech specializes in advanced vestibular solutions designed to diagnose and treat dizziness and balance disorders, pivotal in clinical settings across multiple specialties, including Neurotology, Neurology, Audiology, Physical Therapy, and Ophthalmology. The company’s core products include videonystagmography (VNG) and video-oculography (VOG) systems, which facilitate the evaluation of vestibular function, and video head impulse tests (vHIT) that assess the function of the vestibulo-ocular reflex. Additionally, they offer tools for dynamic visual acuity (DVA) testing, stabilometry platforms for balance assessment, and virtual reality-based vestibular rehabilitation (VRT) systems. These products enable clinicians to provide comprehensive assessments and therapies for both central and peripheral causes of dizziness. Cyclops MedTech's client base includes over 900 clinics and hospitals across 14 countries, serving healthcare professionals who require robust diagnostic and therapeutic tools in the management of vestibular disorders.In the most recent year of 2023, Cyclops MedTech reported revenue of USD 561,928.2 with an EBITDA of USD 42,849.5.Looking ahead, Cyclops MedTech aims to enhance its product line with new vestibular diagnostic tools, planning for launch by 2024. The company intends to expand into additional markets in Southeast Asia and Europe by 2025, utilizing its recent Seed funding of USD 1.00 mn to support product development and market entry initiatives.

## Funding rounds

- Seed, Sep 19, 2018, $1M — Capria Ventures

## Investors

- Capria Ventures (https://capitalatlas.ai/funds/capria-ventures) — Seed